FAST-EU, a pilot initiative that enables an accelerated assessment of multinational clinical trials in the European Union

Last updated: 23 June 2026 For updates, click on the ‘+’ sign below. This post aims to provide basic information on the FAST-EU initiative. The information is by no means exhaustive. What is the FAST-Initiative? FAST-EU (Facilitating and Accelerating Strategic…

Read MoreFAST-EU, a pilot initiative that enables an accelerated assessment of multinational clinical trials in the European Union

Learning from case law: Case C-118/24 AG opinion on whether a drug product licensed via the Article 10(i) of Directive 2001/83 abridged licensing procedure can ever be recognised as a generic of a biologic medicinal product

Last updated: 16 June 2026 To view updates, click on the ‘+’ sign below. This post is an attempt to provide salient information on Case C-118/24 concerning EG Labo Laboratoires Eurogenerics SAS and Theramex France SAS vs the French Regulatory…

Read MoreLearning from case law: Case C-118/24 AG opinion on whether a drug product licensed via the Article 10(i) of Directive 2001/83 abridged licensing procedure can ever be recognised as a generic of a biologic medicinal product